Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

65 results
Display

Letter: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65)

Oh JY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65)

Kim SA, Shim WH, Lee EH, Lee YM, Beom SH, Kim ES, Yoo JS, Nam JS, Cho MH, Park JS, Ahn CW, Kim KR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Cutaneous Plasmacytoma Treated with Bortezomib and Radiotherapy

Jeong KH, Yoon HJ, Lee MH

  • KMID: 2247932
  • Korean J Dermatol.
  • 2009 Apr;47(4):483-486.
Multiple myeloma is a hematologic malignancy characterized by the proliferation of monoclonal plasma cells that produce monoclonal immunoglobulins. Cutaneous involvement is very uncommon in patients with multiple myeloma. It usually...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Synchronous Cholecystectomy and Totally Extraperitoneal (TEP) Herniorrhaphy Using an Umbilical Incision

Suh HH, Cho YK, Rheu HG

Two or more procedures maybe combined into a single surgical event using an abdominal laparoscopic surgery technique. Synchronous operations can provide patients with the advantage of a single hospital stay,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis and therapy of multiple myeloma

Palumbo A, Cerrato C

Many advances in the treatment of multiple myeloma have been made due to the use of transplantation and the introduction of novel agents including thalidomide, lenalidomide, and bortezomib. The first...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of DPP-4 Inhibitors

Kim NH, Kim SG

During past several years, a novel class of antihyperglycemic agents, dipeptidyl peptidase-4 (DPP-4) inhibitors, has become one of the most important options in the management of type 2 diabetes. These...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New Therapeutics for Diabetes Using Incretin Hormone

Oh S

  • KMID: 2259281
  • Korean J Med.
  • 2011 Jun;80(6):625-634.
New therapeutics for type 2 diabetes using incretin hormone were introduced recently. Incretin-based therapies consist of two types: GLP-1 agonists mainly acting on the GLP-1 receptor and dipeptidyl peptidase 4...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bortezomib Induced Tumor Lysis Syndrome in Multiple Myeloma

Yu S, Ryu SW, Kim KH, Kim SH, Lee NS, Park SK, Won JH

  • KMID: 2317696
  • Soonchunhyang Med Sci.
  • 2013 Jun;19(1):31-33.
The tumor lysis syndrome (TLS) commonly occurs in the lymphoproliferative disorder, either spontaneously or in response to therapy. TLS is uncommon in multiple myeloma. However, with the use of bortezomib...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Tinea Corporis Mimicking Erythema Annulare Centrifugum in a Patient Treated with Chemotherapy Due to Multiple Myeloma

Kim EJ, Kim HS, Kim HO, Park YM

  • KMID: 2243099
  • Korean J Med Mycol.
  • 2009 Sep;14(3):150-154.
Tinea corporis usually presents as an erythematous annular plaque with a scaly, concentrically expanding border. However, it is often difficult to diagnose when the initial manifestation is atypical, especially in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pneumothorax during laparoscopic totally extraperitoneal inguinal hernia repair: A case report

Kim HY, Kim TY, Lee KC, Lee MJ, Kim SH, Bahn JM, Choi EK, Kim JY

We experienced an extremely rare complication during performance of laparoscopic totally extraperitoneal (TEP) inguinal hernia repair for a 57-year-old healthy man. About 50 minutes after CO2 insufflation, the patient developed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Laparoscopic total extraperitoneal repair for incarcerated inguinal hernia

Choi YY, Kim Z, Hur KY

PURPOSE: We wanted to measure and compare the patient demographics and perioperative outcomes between patients with incarcerated and patients with non-incarcerated inguinal hernia. METHODS: We conducted a retrospective analysis of 945...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma

Kim Y, Kim KY, Lee SH, Chung YY, Yahng SA, Lee SE, Park G, Min CK

We report on a case of severe hepatotoxicity in a 52-year-old male with multiple myeloma (MM) who had received bortezomib therapy. At patient presentation, liver enzymes were normal, but started...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incretin-based Combination Therapy in Type 2 Diabetes Mellitus

Kim JH, Lee MS

While there are many therapies for type 2 diabetes are available including insulin secretagogues, insulin sensitizers and exogenous insulin, many patients are unable to reach recommended therapeutic targets. Incretin-based therapies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Multiple Solitary Plasmacytoma Recurring in Multiple Visceral Organs

Song IC, Baek SW, Lee KS, Yun GW, Yang YJ, Kim JM, Jo DY

  • KMID: 2258964
  • Korean J Med.
  • 2011 May;80(5):609-614.
Multiple solitary plasmacytoma is a very rare disease entity, which occurs in up to 5% of patients with solitary plasmacytomas. We report an atypical case of multiple solitary plasmacytoma that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Primary Systemic Amyloidosis Confirmed by Various Diagnostic Tools and Repeated Skin Biopsies

Ko BJ, Lee GM, Choi IH, Park YL, Lee SY, Whang KU

  • KMID: 2246593
  • Korean J Dermatol.
  • 2013 Sep;51(9):713-717.
Amyloidosis is a group of disorders resulting from the extracellular deposition of amyloid fibrils in tissues and organs. Primary systemic amyloidosis may be myeloma-associated or idiopathic. It involves the kidney,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Feasibility of Laparoscopic Total Extraperitoneal (TEP) Herniorrhaphy after Previous Lower Abdominal Surgery

Park JH, Choi YY, Hur KY

PURPOSE: We retrospectively reviewed the medical records to estimate the feasibility and surgical outcome of laparoscopic herniorrhaphies in patients with previous lower abdominal surgery. METHODS: Between December 2000 and December 2008,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Successful Allogeneic Stem Cell Transplantation for Chemotherapy-refractory Hepatosplenic gamma delta-T Cell Lymphoma

Kim SB, Jeong SH, Park JH, Kim HS, Kim BK, Lee HS

Hepatosplenic T-cell lymphoma is a rare histologic type of peripheral T-cell lymphoma, which is characterized clinically by predominant involvement of the liver and spleen, with little or no adenopathy, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Totally Extraperitoneal (TEP) Approach for Femoral Hernia

Paik JH, Park YL, Son BH

PURPOSE: The aims of this study were to evaluate the efficacy of laparoscopic totally extraperitoneal (TEP) repair of femoral hernia. METHODS: Eight patients who underwent laparoscopic TEP repair for femoral hernia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical usefulness of laparoscopic total extraperitoneal hernia repair for recurrent inguinal hernia

Jang IS, Lee SM, Kim JH, Kim BS, Choi SI

PURPOSE: Hernia repair after recurrence is a challenging procedure, and many approaches have been suggested for it. Total extraperitoneal (TEP) hernia repair should be considered in recurrent hernia. This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Laparoscopic Inguinal Hernia Repair: A Review of 1,000 Cases

Chung CS, Lee DK

PURPOSE: We reviewed our data compiled prospectively for evaluation of post-operative complications and recurrence of laparoscopic inguinal hernia repair. METHODS: Among the 1000 patients (age, > or =20 years old) who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr